Futura Medical intends to follow up on its success with Eroxon by commercializing a non-prescription treatment for sexual dysfunction in women.
Reporting “positive results” from a study of its topical treatment WSD4000, UK-based Futura said development would continue apace with the goal of securing the necessary regulatory approvals to bring the product to market